Concord Medical Services Holdings Ltd reported that its subsidiary, Concord Healthcare, provided additional information regarding proton therapy services in its 2024 Annual Report, which covers the year ended December 31, 2024. This announcement follows the listing of Concord Healthcare's H shares on the HKSE on January 9, 2024.